Related references
Note: Only part of the references are listed.Bilateral Salpingo-Oophorectomy to Reduce Breast Cancer Risk in Women With Germline BRCA1 or BRCA2 Pathogenic Variants-Caution Needed
Ciara Conduit et al.
JAMA ONCOLOGY (2021)
Bilateral Salpingo-Oophorectomy to Reduce Breast Cancer Risk in Women With Germline BRCA1 or BRCA2 Pathogenic Variants-Caution Needed Reply
Yun-Hee Choi et al.
JAMA ONCOLOGY (2021)
Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium
Hongyan Li et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial
Jack Cuzick et al.
LANCET (2020)
Five year letrozole versus placebo in BRCA1/2 germline mutations carriers: Final results of LIBER, a double-blind randomized phase III breast cancer prevention trial.
Pascal Pujol et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Association of premenopausal risk-reducing salpingo-oophorectomy with breast cancer risk in BRCA1/2 mutation carriers: Maximising bias-reduction
Neda Stjepanovic et al.
EUROPEAN JOURNAL OF CANCER (2020)
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants
Daniel R. Barnes et al.
GENETICS IN MEDICINE (2020)
Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199)
Phuong L. Mai et al.
JNCI CANCER SPECTRUM (2020)
Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
Nasim Mavaddat et al.
BREAST CANCER RESEARCH (2020)
Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk
Mary Beth Terry et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation
Kelly Metcalfe et al.
BRITISH JOURNAL OF CANCER (2019)
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia
Andrea DeCensi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Hereditary breast cancer; Genetic penetrance and current status with BRCA
Morteza Mahdavi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression
Chuying Wang et al.
BREAST CANCER RESEARCH (2018)
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Joanne Kotsopoulos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Joanne Kotsopoulos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
RE: Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Emma Nolan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
RE: Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Emma Nolan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening
S. Paluch-Shimon et al.
ANNALS OF ONCOLOGY (2016)
Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review
Xiao Li et al.
CLINICAL CANCER RESEARCH (2016)
Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers
Roger L. Milne et al.
ENDOCRINE-RELATED CANCER (2016)
The rise of multiple imputation: a review of the reporting and implementation of the method in medical research
Panteha Hayati Rezvan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2015)
Association of Type and Location of BRCA1 and BRCA2 Mutations With Risk of Breast and Ovarian Cancer
Timothy R. Rebbeck et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Untitled RESPONSE
B. A. M. Heemskerk-Gerritsen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction
B. A. M. Heemskerk-Gerritsen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction
Xinglei Chai et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial
Jack Cuzick et al.
LANCET ONCOLOGY (2015)
Untitled RESPONSE
B. A. M. Heemskerk-Gerritsen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction
Xinglei Chai et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction
B. A. M. Heemskerk-Gerritsen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
Kelly Metcalfe et al.
JAMA ONCOLOGY (2015)
Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation
Amy P. M. Finch et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Oophorectomy, estrogen, and dementia: A 2014 update
Walter A. Rocca et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis
B. A. M. Heemskerk-Gerritsen et al.
ANNALS OF ONCOLOGY (2013)
Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral
Sarah L. Ingham et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
Nasim Mavaddat et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data
Jack Cuzick et al.
LANCET (2013)
Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers
Ian M. Collins et al.
MEDICAL JOURNAL OF AUSTRALIA (2013)
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
Fergus J. Couch et al.
PLOS GENETICS (2013)
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
Nasim Mavaddat et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review
Furu Wang et al.
MOLECULAR BIOLOGY REPORTS (2012)
Breast cancer after bilateral risk-reducing mastectomy
A-B Skytte et al.
CLINICAL GENETICS (2011)
BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells
Gemma Molyneux et al.
CELL STEM CELL (2010)
Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
Susan M. Domchek et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
Timothy R. Rebbeck et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses' Health Study
William H. Parker et al.
OBSTETRICS AND GYNECOLOGY (2009)
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
Antonis C. Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers
Kelly A. Metcalfe et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer:: A multicenter, prospective study
Noah D. Kauff et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERα-negative and ERα-positive mammary preneoplasia and cancer
L. P. Jones et al.
ONCOGENE (2008)
A role of estrogen/ERα signaling in BRCA1-associated tissue-specific tumor formation
W. Li et al.
ONCOGENE (2007)
Effect of early menopause on bone mineral density and fractures
J. Christopher Gallagher
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2007)
Age at menarche and menopause and breast cancer risk in the international BRCA1/2 Carrier Cohort Study
Jenny Chang-Claude et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Survival patterns after oophorectomy in premenopausal women: a population-based cohort study
Walter A. Rocca et al.
LANCET ONCOLOGY (2006)
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers:: a prospective cohort study
SM Domchek et al.
LANCET ONCOLOGY (2006)
Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers
JL Kramer et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Breast cancer risk following bilateral oophorectorny in BRCA1 and BRCA2 mutation carriers:: An international case-control study
A Eisen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Genomic rearrangements in the BRCA1 and BRCA2 genes
S Mazoyer
HUMAN MUTATION (2005)
Estrogen receptor status in BRCA1- and BRCA2-related breast cancer:: The influence of age, grade, and histological type
WD Foulkes et al.
CLINICAL CANCER RESEARCH (2004)
Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy
M Robson et al.
GYNECOLOGIC ONCOLOGY (2003)
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
ND Kauff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations
TR Rebbeck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2 -: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial
MC King et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
